Partnering & Outsourcing Editorial
-
Government Contract Advances Walgreens In Clinical Space
8/1/2024
Walgreen’s new $25 million deal with BARDA (Biomedical Advanced Research and Development Authority) is a huge win for the pharmacy chain. John Campbell, head of DCTs at Walgreens, explains the ins and outs of the study and what could be next for the company regarding its clinical trials division.
-
Why Moving More Cancer Trials Into The Community Benefits Patients And Sponsors
7/29/2024
Amita Patnaik, MS, FRCPC recounts the growth and necessity of START’s locations and site network amid the perpetual need to bring clinical research, especially for cancer, closer to patients.
-
Sites To Sponsors: Have A Little More Trust
7/24/2024
Atlas Clinical Research CEO Mark Scullion says trust should be the foundation of a proper site-sponsor relationship and posits that site networks are at an advantage to do just that.
-
A Look At 5 Years Of CRO Leadership Awards
7/9/2024
Are the same companies winning the CRO Leadership Awards year over year? I decided to look back at the data to find out.
-
Getting A Grasp On CRO Selection
6/25/2024
Companies can spend a great deal of time negotiating preferred provider agreements (PPAs), and their presence, or lack thereof, can make or break which CROs are shortlisted or awarded a Phase II/III study.
-
Storyboarding: The Secret Weapon Of GCP Quality Assurance
6/6/2024
Discover how storyboards in GCP quality assurance can serve as a framework for crafting clear, consistent messaging that resonates across inspection teams with GCP consultant Donatella Ballerini.
-
Is Your Intellectual Property Safe With Indian CROs And CDMOs?
6/3/2024
Startups and Big Pharma companies alike are considering India as an alternative to working with China. Is it safe to do business with India? Let's do a deep dive, with insights from American and Indian attorneys.
-
Reeve Foundation Advances SCI Trials And Treatments With Symposium, Partnerships
5/28/2024
Reeve Foundation CSO Mario Baptista, Ph.D., delves into the current landscape of SCI clinical trials, exploring the challenges that continue to impede progress and the strategies being employed to overcome them.
-
Clinical Outsourcing Observations And Predictions
5/22/2024
Industry expert Samir Shah talks about why the FSP model is so popular these days and how site networks could become a replacement for CROs in some situations. He also suggests a new type of contracting model that could save sponsors and sites money.
-
The Best Advice I Ever Got: On The Job
5/22/2024
To commemorate Clinical Trials Day 2024, Clinical Leader tapped its community of clinical research professionals to share their insights — from individual efforts to partnership best practices to trial design and more.